InMed Pharmaceuticals Inc. financial data

Symbol
INM on Nasdaq
Industry
Pharmaceutical Preparations
Location
1445 885 West Georgia St., Vancouver, British Columbia, Canada
State of incorporation
British Columbia, Canada
Fiscal year end
June 30
Latest financial report
10-Q - Q4 2024 - Feb 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 594 % +77.2%
Quick Ratio 66.2 % +18.8%
Debt-to-equity 29.6 % -7.42%
Return On Equity -91.8 % +38.7%
Return On Assets -46.2 % +59.3%
Operating Margin -148 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.21M shares -80.1%
Common Stock, Shares, Outstanding 724K shares -87.2%
Entity Public Float 2.35M USD -26.1%
Common Stock, Value, Issued 84.5M USD +5.76%
Weighted Average Number of Shares Outstanding, Basic 707K shares +77.2%
Weighted Average Number of Shares Outstanding, Diluted 707K shares +77.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.11M USD -10.4%
Cost of Revenue 651K USD -29%
Research and Development Expense 1.06M USD +73.9%
General and Administrative Expense 1.55M USD +13.9%
Costs and Expenses -2.34M USD +37.1%
Operating Income (Loss) -6.97M USD +63.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -2.58M USD -74.2%
Net Income (Loss) Attributable to Parent -2.58M USD -74.2%
Earnings Per Share, Basic -3.64 USD/shares +1.89%
Earnings Per Share, Diluted -3.64 USD/shares +1.89%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.42M USD -64.1%
Cash, Cash Equivalents, and Short-term Investments 3.5M USD -63.2%
Accounts Receivable, after Allowance for Credit Loss, Current 263K USD -29.6%
Inventory, Net 1.1M USD +48.1%
Assets, Current 5.47M USD -53.7%
Property, Plant and Equipment, Net 1.23M USD -16.9%
Intangible Assets, Net (Excluding Goodwill) 1.7M USD -8.75%
Other Assets, Noncurrent 100K USD 0%
Assets 8.5M USD -44.3%
Accounts Payable, Current 2K USD
Employee-related Liabilities, Current 337K USD +231%
Accrued Liabilities, Current 85.5K USD
Liabilities, Current 1.79M USD +6.57%
Operating Lease, Liability, Noncurrent 529K USD -34.1%
Liabilities 2.32M USD -6.57%
Accumulated Other Comprehensive Income (Loss), Net of Tax 129K USD 0%
Retained Earnings (Accumulated Deficit) -113M USD -7.51%
Stockholders' Equity Attributable to Parent 6.18M USD -51.6%
Liabilities and Equity 8.5M USD -44.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.83M USD +16%
Net Cash Provided by (Used in) Financing Activities 838K USD
Common Stock, Shares, Issued 724K shares -87.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.42M USD -64.1%
Deferred Tax Assets, Valuation Allowance 22.7M USD +7.73%
Deferred Tax Assets, Gross 22.7M USD +7.73%
Operating Lease, Liability 949K USD -18.7%
Depreciation 12.2K USD -14.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -15.5M USD -10.7%
Lessee, Operating Lease, Liability, to be Paid 1.01M USD -22.1%
Property, Plant and Equipment, Gross 2.37M USD
Operating Lease, Liability, Current 420K USD +15.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 313K USD -15.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 469K USD +29.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 63.6K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 219K USD -80%
Additional Paid in Capital 38.1M USD -0.74%
Amortization of Intangible Assets 42.8K USD +4.46%
Depreciation, Depletion and Amortization 54.6K USD -0.46%
Share-based Payment Arrangement, Expense 23.2K USD +26.8%